| Lower associated costs using rifampicin-miconazole‒impregnated catheters compared with standard catheters. | |
| | |
MedLine Citation:
|
PMID: 21741122 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Previous cost-effectiveness analyses found that antibiotic-impregnated catheters decrease the incidence of catheter-related bloodstream infection (CRBSI) as well as the costs related to central venous catheter (CVC) use, including increased hospital length of stay. The effect varied greatly among the studies, however. In this retrospective cohort study, compared with standard catheters, the use of rifampicin-miconazole-impregnated catheters was associated with lower CRBSI incidence and immediate CVC-related costs (taking into account only the costs of CVC, diagnosis, and treatment of CRBSI) (P < .001). Our data indicate that the use of rifampicin-miconazole-impregnated catheters can save associated costs. |
| | |
Authors:
|
Leonardo Lorente; María Lecuona; María José Ramos; Alejandro Jiménez; María L Mora; Antonio Sierra |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-7-6 |
Journal Detail:
|
Title: American journal of infection control Volume: - ISSN: 1527-3296 ISO Abbreviation: - Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-7-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8004854 Medline TA: Am J Infect Control Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved. |
Affiliation:
|
Department of Critical Care, Hospital of the University of Canarias, Santa Cruz de Tenerife, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Control of Legionella contamination in a hospital water distribution system by monochloramine.
Next Document: Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotro...